Bleeding and Platelet Disorders

Gene: TBXA2R

Amber List (moderate evidence)

TBXA2R (thromboxane A2 receptor)
EnsemblGeneIds (GRCh38): ENSG00000006638
EnsemblGeneIds (GRCh37): ENSG00000006638
OMIM: 188070, Gene2Phenotype
TBXA2R is in 2 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Susceptibility to platelet-type bleeding disorder-13 is due to a defective thromboxane A2 receptor on platelets. The susceptibility is inherited in an autosomal dominant pattern, but clinical features, including mild mucocutaneous bleeding, occur only in the presence of a 'second hit' affecting platelet function; this second hit may be either in the TBXA2R gene or in another gene affecting the coagulation cascade. Amber rating as not clearly a Mendelian disorder.
Created: 4 Jun 2021, 2 a.m. | Last Modified: 4 Jun 2021, 2 a.m.
Panel Version: 0.297

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
{Bleeding disorder, platelet-type, 13, susceptibility to}, MIM# 614009

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Victorian Clinical Genetics Services
Phenotypes
  • {Bleeding disorder, platelet-type, 13, susceptibility to}, MIM# 614009
OMIM
188070
Clinvar variants
Variants in TBXA2R
Penetrance
None
Publications
Panels with this gene

History Filter Activity

4 Jun 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: tbxa2r has been classified as Amber List (Moderate Evidence).

4 Jun 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: TBXA2R were changed from to {Bleeding disorder, platelet-type, 13, susceptibility to}, MIM# 614009

4 Jun 2021, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: TBXA2R were set to

4 Jun 2021, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: TBXA2R was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

4 Jun 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: tbxa2r has been classified as Amber List (Moderate Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: TBXA2R was added gene: TBXA2R was added to Bleeding Disorders_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: TBXA2R was set to Unknown